Clough Capital Partners L P Makes New $1.11 Million Investment in Docusign Inc. $DOCU

Key Points

• Clough Capital Partners L P has acquired 13,688 shares of Docusign Inc., valued at approximately $1.11 million, as reported in their recent SEC filing.
• Docusign's recent quarterly earnings showed an upward revenue trend of 7.6% year-over-year, with an earnings per share (EPS) of $0.90, surpassing expectations.
• The company approved a $1 billion share repurchase plan, indicating management's belief that its shares are undervalued.

Clough Capital Partners L P bought a new stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 13,688 shares of the company's stock, valued at approximately $1,114,000.

Several other institutional investors and hedge funds also recently made changes to their positions in DOCU. Hemington Wealth Management boosted its position in shares of Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares in the last quarter. Golden State Wealth Management LLC boosted its position in shares of Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after purchasing an additional 322 shares in the last quarter. Summit Securities Group LLC bought a new stake in shares of Docusign during the 1st quarter valued at about $34,000. Wood Tarver Financial Group LLC acquired a new position in Docusign during the 4th quarter worth approximately $37,000. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in Docusign by 153.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock worth $37,000 after acquiring an additional 274 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Docusign Stock Performance

Shares of Docusign stock traded up $1.15 on Monday, hitting $76.66. The company had a trading volume of 2,272,539 shares, compared to its average volume of 2,322,855. The stock has a market capitalization of $15.49 billion, a price-to-earnings ratio of 14.49, a P/E/G ratio of 28.61 and a beta of 1.02. Docusign Inc. has a 1 year low of $54.31 and a 1 year high of $107.86. The stock has a 50 day moving average of $75.46 and a 200-day moving average of $79.59.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, June 5th. The company reported $0.90 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The company had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. During the same period last year, the business posted $0.82 earnings per share. Docusign's revenue was up 7.6% on a year-over-year basis. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign announced that its Board of Directors has initiated a stock buyback program on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its stock is undervalued.

Insider Buying and Selling

In other news, insider Robert Chatwani sold 22,875 shares of Docusign stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the transaction, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 40,000 shares of Docusign stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the transaction, the chief executive officer owned 143,983 shares of the company's stock, valued at approximately $11,160,122.33. This trade represents a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 78,552 shares of company stock valued at $5,983,631 in the last ninety days. 1.01% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DOCU shares. Wall Street Zen lowered Docusign from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Robert W. Baird cut their price target on Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a report on Friday, June 6th. JPMorgan Chase & Co. cut their price target on Docusign from $81.00 to $77.00 and set a "neutral" rating on the stock in a report on Friday, June 6th. Wedbush cut their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, June 12th. Finally, Wells Fargo & Company upgraded Docusign from an "underweight" rating to an "equal weight" rating and increased their price target for the stock from $67.00 to $80.00 in a report on Friday, June 13th. Four investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $89.77.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.